eClinicalMedicine in conversation with

Riccardo De Giorgi joins Elena Bellafante, Deputy Editor for eClinicalMedicine, to discuss the evidence that semaglutide may be associated with a reduced risk of a number of neurological and psychiatric outcomes, including cognitive deficits and dementia, as well as nicotine misuse.

Read the full article:
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00305-5/fulltext?dgcid=buzzsprout_tlv_podcast_generic_eclinm

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv